Ironwood Pharmaceuticals IRWD Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's operating income?
- Ironwood Pharmaceuticals (IRWD) reported operating income of $72.57M in Q1 2026.
- How has Ironwood Pharmaceuticals's operating income changed year-over-year?
- Ironwood Pharmaceuticals's operating income increased by 349.3% year-over-year, from -$29.11M to $72.57M.
- What is the long-term trend for Ironwood Pharmaceuticals's operating income?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's operating income has grown at a -19.3% compound annual growth rate (CAGR), from $232.26M to $98.5M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.